Literature DB >> 23079675

Where are we on worms?

David E Elliott1, Joel V Weinstock.   

Abstract

PURPOSE OF REVIEW: There is something about living in an industrialized country that dramatically increases the risk of acquiring inflammatory bowel disease (IBD). Loss of routine exposure to parasitic worms (helminths), due to modern highly hygienic life styles, likely contributes to this risk. This article reviews current understanding on how helminths influence intestinal inflammation and mucosal immune responses. RECENT
FINDINGS: IBD emerges in populations as regions develop socioeconomically and lose exposure to previously ubiquitous helminthic infections. Helminthic infections provided strong selective pressure for the dissemination of gene variants, many of which predispose to development of IBD. In animal models of IBD, helminth colonization suppresses intestinal inflammation through multiple mechanisms including induction of innate and adaptive regulatory circuits. Trials using helminths like hookworm (Necator americanus) or porcine whipworm (Trichuris suis) show that they are safe and may be effective therapies for the control of the aberrant intestinal inflammation seen in Crohn's disease and ulcerative colitis.
SUMMARY: Evidence is accumulating that highly hygienic living conditions create risk for developing immune-mediated disease such as IBD. To live in their host, helminths have developed the ability to activate cells of innate and adaptive immunity that suppress inflammation. Therapeutic trials using helminths are in progress.

Entities:  

Mesh:

Year:  2012        PMID: 23079675      PMCID: PMC3744105          DOI: 10.1097/MOG.0b013e3283572f73

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  49 in total

1.  A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors.

Authors:  J Croese; J O'neil; J Masson; S Cooke; W Melrose; D Pritchard; R Speare
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

2.  Amelioration of intestinal colitis by macrophage migration inhibitory factor isolated from intestinal parasites through toll-like receptor 2.

Authors:  M K Cho; C H Lee; H S Yu
Journal:  Parasite Immunol       Date:  2011-05       Impact factor: 2.280

3.  Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis.

Authors:  Meaghan M Hunter; Arthur Wang; Christina L Hirota; Derek M McKay
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

4.  Epidemiology and natural history of inflammatory bowel diseases.

Authors:  Jacques Cosnes; Corinne Gower-Rousseau; Philippe Seksik; Antoine Cortot
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

5.  Increasing incidence of inflammatory bowel disease among young men in Korea between 2003 and 2008.

Authors:  Dong Hyuk Shin; Dong Hyun Sinn; Young-Ho Kim; Jin Yong Kim; Dong Kyung Chang; Eun Jin Kim; Ho Yoel Ryu; Han Ul Song; Il Young Kim; Do Hyoung Kim; Yun Young Kim; Suk Hun Kim; Yu Bin Seo; Ki Won Hwang; Jae J Kim
Journal:  Dig Dis Sci       Date:  2010-09-16       Impact factor: 3.199

6.  Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production.

Authors:  David E Elliott; Ahmed Metwali; John Leung; Tommy Setiawan; Arthur M Blum; M Nedim Ince; Lindsey E Bazzone; Miguel J Stadecker; Joseph F Urban; Joel V Weinstock
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

7.  A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages.

Authors:  Corinna Schnoeller; Sebastian Rausch; Smitha Pillai; Angela Avagyan; Bianca M Wittig; Christoph Loddenkemper; Alf Hamann; Eckard Hamelmann; Richard Lucius; Susanne Hartmann
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

8.  Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil.

Authors:  Carlos Roberto Victoria; Ligia Yukie Sassak; Hélio Rubens de Carvalho Nunes
Journal:  Arq Gastroenterol       Date:  2009 Jan-Mar

9.  Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection.

Authors:  Henry J McSorley; Soraya Gaze; James Daveson; Dianne Jones; Robert P Anderson; Andrew Clouston; Nathalie E Ruyssers; Richard Speare; James S McCarthy; Christian R Engwerda; John Croese; Alex Loukas
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

10.  Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice.

Authors:  Alexandra Melon; Arthur Wang; Van Phan; Derek M McKay
Journal:  J Biomed Biotechnol       Date:  2010
View more
  24 in total

Review 1.  Role of type 2 immunity in intestinal inflammation.

Authors:  Giorgos Bamias; Fabio Cominelli
Journal:  Curr Opin Gastroenterol       Date:  2015-11       Impact factor: 3.287

2.  Immunomodulatory effects of Trichinella spiralis-derived excretory-secretory antigens.

Authors:  Ivana Radovic; Alisa Gruden-Movsesijan; Natasa Ilic; Jelena Cvetkovic; Slavko Mojsilovic; Marija Devic; Ljiljana Sofronic-Milosavljevic
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

3.  Globule Leukocytes and Other Mast Cells in the Mouse Intestine.

Authors:  Peter Vogel; Laura Janke; David M Gravano; Meifen Lu; Deepali V Sawant; Dorothy Bush; E Shuyu; Dario A A Vignali; Asha Pillai; Jerold E Rehg
Journal:  Vet Pathol       Date:  2017-05-11       Impact factor: 2.221

Review 4.  Role in Allergic Diseases of Immunological Cross-Reactivity between Allergens and Homologues of Parasite Proteins.

Authors:  Helton da Costa Santiago; Thomas B Nutman
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

5.  Helminth infection alters IgE responses to allergens structurally related to parasite proteins.

Authors:  Helton da Costa Santiago; Flávia L Ribeiro-Gomes; Sasisekhar Bennuru; Thomas B Nutman
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

6.  Increased susceptibility to Trichuris muris infection and exacerbation of colitis in Mdr1a-/- mice.

Authors:  Ekta K Bhardwaj; Kathryn J Else; Michael T Rogan; Geoffrey Warhurst
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 7.  Human Helminths and Allergic Disease: The Hygiene Hypothesis and Beyond.

Authors:  Helton C Santiago; Thomas B Nutman
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

8.  Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases.

Authors:  Sandeep Chhabra; Shih Chieh Chang; Hai M Nguyen; Redwan Huq; Mark R Tanner; Luz M Londono; Rosendo Estrada; Vikas Dhawan; Satendra Chauhan; Sanjeev K Upadhyay; Mariel Gindin; Peter J Hotez; Jesus G Valenzuela; Biswaranjan Mohanty; James D Swarbrick; Heike Wulff; Shawn P Iadonato; George A Gutman; Christine Beeton; Michael W Pennington; Raymond S Norton; K George Chandy
Journal:  FASEB J       Date:  2014-06-02       Impact factor: 5.191

9.  Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infection.

Authors:  Parakkal Jovvian George; Nathella Pavan Kumar; Jeeva Jaganathan; Chandrakumar Dolla; Paul Kumaran; Dina Nair; Vaithilingam V Banurekha; Kui Shen; Thomas B Nutman; Subash Babu
Journal:  Tuberculosis (Edinb)       Date:  2015-10-08       Impact factor: 3.131

10.  The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr mice.

Authors:  David T Rodgers; Mairi A McGrath; Miguel A Pineda; Lamyaa Al-Riyami; Justyna Rzepecka; Felicity Lumb; William Harnett; Margaret M Harnett
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.